Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2023-03-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation
NCT03239262
Hemolysis During Pulsed-field and Radiofrequency Ablation
NCT06096428
The Effect of Pulsed-field and Radiofrequency Ablation on Platelet, Coagulation and Inflammation
NCT05603637
Left Atrial Function After Pulsed Field Ablation of Atrial Fibrillation
NCT06478342
Continuous Versus Discontinuous Design of Encircling Lesions During Ablation for Atrial Fibrillation
NCT03332862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Measuring heart rate variability is a simple non-invasive method. A regular ECG Holter recorder can be used for the measurement. Patients will be fitted with a 24-hour Holter ECG on admission to determine the original heart rate variability. Catheter ablation will take place the next day. Patients will be treated using one of two methods of pulmonary vein isolation - RFA or PFA. One month after the catheterization procedure, a 24-hour Holter ECG will be used again to detect changes in HRV compared to preoperative values.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PFA group
Patients undergoing pulsed field ablation
Holter EKG - 1 day before ablation
24 hours Holter EKG - 1 day before ablation
Pulsed field ablation
Pulmonary vein isolation using pulsed field ablation
Holter EKG - 1 month after ablation
24 hours Holter EKG 1 month after ablation
RFA group
Patients undergoing radiofrequency ablation
Holter EKG - 1 day before ablation
24 hours Holter EKG - 1 day before ablation
Radiofrequency ablation
Pulmonary vein isolation using radiofrequency ablation
Holter EKG - 1 month after ablation
24 hours Holter EKG 1 month after ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Holter EKG - 1 day before ablation
24 hours Holter EKG - 1 day before ablation
Radiofrequency ablation
Pulmonary vein isolation using radiofrequency ablation
Pulsed field ablation
Pulmonary vein isolation using pulsed field ablation
Holter EKG - 1 month after ablation
24 hours Holter EKG 1 month after ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication for catheter ablation due to atrial fibrillation
* willingness to participate
Exclusion Criteria
* significant valve disease
* left ventricular dysfunction, EF less than 35%
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vascular surgery, University hospital Královské Vinohrady, Prague
OTHER
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.